Straumann Holding Ltd. was founded in 1954 and is headquartered in Basel, Switzerland. The company engages in implants, and restorative and regenerative dentistry. Straumann researches, develops and manufactures dental implants, instruments, prosthetics, tissue and bone regeneration biomaterials for use in tooth replacement and restoration, as well as to prevent tooth loss. More than 15 million company implants have been placed worldwide.
Straumann offers a broad range of products and solutions for both conventional treatment and digital workflows, including guided surgery, intraoral scanning and CAD/CAM restorations. The company also collaborates with clinics, research institutes and universities and contributes over 100 scientific publications annually.
The Straumann group operates 6 production sites in Europe, the United States and Japan and employs approximately 3,400 people worldwide. Company products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.
The company’s nine-month revenue for fiscal 2019 increased by 16% and exceeded CHF 1bn for the first time. Follow and trade STMN.ZU for more news and updates.